0001725160-24-000140.txt : 20240621 0001725160-24-000140.hdr.sgml : 20240621 20240621170627 ACCESSION NUMBER: 0001725160-24-000140 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240621 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823607803 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 241061311 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 263-4333 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 8-K 1 zntl-20240621.htm 8-K zntl-20240621
0001725160FALSE00017251602024-06-212024-06-21


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
——————————————

FORM 8-K
——————————————

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 21, 2024

——————————————  
ZENTALIS PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)   
——————————————
Delaware 001-39263 82-3607803
(State or other jurisdiction
of incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
10275 Science Center Drive, Suite 200
San Diego, California 92121
(Address of principal executive offices) (Zip Code)
(858) 263-4333
(Registrant’s telephone number, include area code)
1359 Broadway, Suite 801
New York, New York 10018
(Former name or former address, if changed since last report)  
——————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
 
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
 
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 



Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareZNTLThe Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 



Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 21, 2024, Zentalis Pharmaceuticals, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, a total of 66,107,445 shares of common stock were present online or represented by proxy at the meeting, representing approximately 93.09% of the Company’s outstanding common stock as of the April 23, 2024 record date. The following are the voting results for the proposals considered and voted upon at the Annual Meeting, all of which were described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 29, 2024.

Item 1 — Election of two Class I directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal.
NOMINEE
Votes FOR
Votes WITHHELD
Broker Non-Votes
Kimberly Blackwell, M.D.
48,055,58412,810,3705,241,491
Enoch Kariuki, Pharm.D.
45,008,37815,857,5765,241,491

Item 2 — Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
66,098,0835,6653,697
0

Item 3 — Approval, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers.

Votes FOR
Votes AGAINST
Votes ABSTAINED
Broker Non-Votes
36,128,13024,729,7308,0945,241,491

Based on the foregoing votes, Kimberly Blackwell, M.D., and Enoch Kariuki, Pharm.D., were elected as Class I Directors and Items 2 and 3 were approved.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 ZENTALIS PHARMACEUTICALS, INC.
Date: June 21, 2024 By: /s/ Kimberly Blackwell, M.D.
  Kimberly Blackwell, M.D.
  Chief Executive Officer

 EX-101.SCH 2 zntl-20240621.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 zntl-20240621_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 zntl-20240621_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Soliciting Material Soliciting Material Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Information [Line Items] Document Information [Line Items] City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Addresses [Line Items] Entity Addresses [Line Items] Entity Tax Identification Number Entity Tax Identification Number Entity Addresses [Table] Entity Addresses [Table] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, City or Town Entity Address, City or Town Local Phone Number Local Phone Number Written Communications Written Communications Cover [Abstract] Document Type Document Type Document Information [Table] Document Information [Table] Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 zntl-20240621_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Jun. 21, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 21, 2024
Entity Registrant Name ZENTALIS PHARMACEUTICALS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39263
Entity Tax Identification Number 82-3607803
Entity Address, Address Line One 10275 Science Center Drive
Entity Address, Address Line Two Suite 200
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 263-4333
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol ZNTL
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001725160
Amendment Flag false
Entity Addresses [Line Items]  
Entity Address, Address Line One 10275 Science Center Drive
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.zentalis.com/role/Cover Cover Cover 1 false false All Reports Book All Reports zntl-20240621.htm zntl-20240621.xsd zntl-20240621_def.xml zntl-20240621_lab.xml zntl-20240621_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "zntl-20240621.htm": { "nsprefix": "zntl", "nsuri": "http://www.zentalis.com/20240621", "dts": { "inline": { "local": [ "zntl-20240621.htm" ] }, "schema": { "local": [ "zntl-20240621.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "definitionLink": { "local": [ "zntl-20240621_def.xml" ] }, "labelLink": { "local": [ "zntl-20240621_lab.xml" ] }, "presentationLink": { "local": [ "zntl-20240621_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "report": { "R1": { "role": "http://www.zentalis.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "zntl-20240621.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "zntl-20240621.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentInformationTable", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressesLineItems", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Addresses [Line Items]", "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressesTable", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Addresses [Table]", "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r1" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://www.zentalis.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001725160-24-000140-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001725160-24-000140-xbrl.zip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end XML 17 zntl-20240621_htm.xml IDEA: XBRL DOCUMENT 0001725160 2024-06-21 2024-06-21 0001725160 false 8-K 2024-06-21 ZENTALIS PHARMACEUTICALS, INC. DE 001-39263 82-3607803 10275 Science Center Drive Suite 200 San Diego CA 92121 858 263-4333 false false false false Common Stock, $0.001 par value per share ZNTL NASDAQ false